Can a Urinalysis (UA) detect Bence Jones proteins, specifically light chains, in the urine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

No, a urinalysis (UA) cannot detect light chains in the urine, and specialized testing such as urine protein electrophoresis (UPEP) or immunofixation electrophoresis (IFE) is required for detection. Light chains, which are components of immunoglobulins produced by plasma cells, require these specific tests for identification and quantification. According to the most recent and highest quality study, a 24-hour urine collection for protein electrophoresis is the recommended test for detecting Bence Jones proteins, specifically light chains, in the urine 1. Standard urinalysis can detect protein in general through dipstick testing, but it cannot distinguish between different types of proteins or specifically identify light chains. The dipstick primarily detects albumin and is relatively insensitive to light chains due to their lower molecular weight and different chemical properties.

Key Points

  • Urinalysis (UA) is not sufficient for detecting light chains in the urine
  • Specialized testing such as urine protein electrophoresis (UPEP) or immunofixation electrophoresis (IFE) is required for detection
  • A 24-hour urine collection for protein electrophoresis is the recommended test for detecting Bence Jones proteins, specifically light chains, in the urine
  • Serum free light-chain (FLC) measurement can be used for screening and monitoring, but it cannot replace the 24-hour UPEP for monitoring patients with measurable urinary M-protein 1

Clinical Implications

The inability of urinalysis to detect light chains in the urine has significant clinical implications. If light chain detection is clinically indicated, as in cases of suspected multiple myeloma, amyloidosis, or other plasma cell disorders, the appropriate test to order would be a 24-hour urine collection for protein electrophoresis rather than a standard urinalysis. This is because the detection of light chains is crucial for the diagnosis and management of these conditions, and specialized testing is required to ensure accurate diagnosis and monitoring. As stated in the study, the serum FLC assay cannot replace the 24-hour UPEP for monitoring patients with measurable urinary M-protein and can also be affected by renal function 1.

From the Research

Urinalysis and Bence Jones Proteins

  • Urinalysis (UA) can detect Bence Jones proteins, specifically light chains, in the urine, but the sensitivity of conventional assays may be limited 2, 3, 4.
  • Studies have shown that urine immunofixation electrophoresis is more sensitive than conventional assays for detecting monoclonal light chains in urine 2.
  • The detection of monoclonal free light chains in urine can be an important marker for minimal residual disease in multiple myeloma 2, 5.
  • However, serum free light chain measurements have been shown to be more sensitive and have better prognostic value than urine measurements for monitoring light-chain multiple myeloma 3.
  • Unexpected migration of free light chains in urinary protein electrophoresis can lead to misinterpretation of results, highlighting the need for comprehensive interpretation of UA results 6.
  • Early detection of monoclonal immunoglobulin light chains in the urine can be important in clinical diagnosis, therapy, and follow-up of patients with lymphoproliferative diseases 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.